Chronic renal failure produces anemia that requires stimulating the body to produce more red blood cells; GEREPO is a recombinant biological erythropoietin (epoetin) given by injection to dialysis patients to raise hemoglobin levels into the target therapeutic range.
Key Benefits:
• Raises hemoglobin levels and improves symptoms of chronic renal anemia
• Demonstrated therapeutic equivalence to standard epoetin products in clinical trials
• Reduces the need for blood transfusions in patients with renal failure
• Improves energy levels and daily activity capacity in patients
Key Ingredients:
• Recombinant biological erythropoietin (epoetin) as the active substance
• Sterile injection vehicle excipients (human albumin or polysorbate with sodium phosphate buffer)
How to Use: Administered under medical supervision by intravenous or subcutaneous injection at the dose prescribed by the treating physician.
